Back to top

Latest News

17 February 2014

NDS News Update

NDIS receives its first half-yearly report

The first six-monthly National Disability Insurance Scheme (NDIS) report shows that the average size of packages in trial sites is falling (but still 15% above the benchmark), and that planning is slow. A plan takes an average of 63 days to...

12 February 2014

New international survey on bladder and bowel issues

The Multiple Sclerosis International Federation, in line with the next edition of their magazine 'MS in Focus' is conducting an international (anonymous) survey of people with MS who experience bladder and bowel issues.

The survey, which is only available in English, should only...

12 February 2014

New international survey on bladder and bowel issues

The Multiple Sclerosis International Federation, in line with the next edition of their magazine 'MS in Focus' is conducting an international (anonymous) survey of people with MS who experience bladder and bowel issues.

The survey, which is only available in English, should only...

5 February 2014

Queensland researchers make major breakthrough in MS treatment

NEW Queensland research suggests that controlling infection with Epstein-Barr virus (EBV) – the most common cause of glandular fever – may be beneficial in treating multiple sclerosis (MS), a chronic inflammatory demyelinating disease of the brain and spinal cord affecting more than 23,000...

30 January 2014

National Disability Services Congratulates Australia Day Honours Recipients

NDS congratulates Honours recipients

National Disability Services congratulates the recipients of Australia Day 2014 Honours. This year's list has more than 25 citizens whose work with...

29 January 2014

Carer mobilises community behind Multiple Sclerosis Treatment

Sunbury carer and mother of three Brenda Fisher, has secured more than 10,000 signatures supporting improved treatment choices for people with Multiple Sclerosis (MS).

Brenda, whose husband Mark was diagnosed with MS more than 18 years ago, has rallied the community behind her call for...

29 January 2014

Carer mobilises community behind Multiple Sclerosis Treatment

Sunbury carer and mother of three Brenda Fisher, has secured more than 10,000 signatures supporting improved treatment choices for people with Multiple Sclerosis (MS).

Brenda, whose husband Mark was diagnosed with MS more than 18 years ago, has rallied the community behind her call for...

17 January 2014

Public submissions now open for Pharmacuetical Benefits Advisory Committee March meeting

The public commentary period for the next round of Pharmaceutical Benefits Advisory Committee (PBAC) considerations is now open.

MS treatment Fampyra -produced by Biogen Idec - is being considered for subsidisation by the Federal Government through the PBAC this March.

Fampyra (...

17 January 2014

Sharing news of a diagnosis could be key to people with MS retaining employment

Researchers have discovered that people with Multiple Sclerosis (MS) may be better off disclosing their diagnosis to their employer rather than staying quiet about their MS.

Dr Pieter Van Dijk and Dr Andrea Kirk-Brown from Monash University, in collaboration with Dr Rex Simmons from...

20 November 2013

Collaroy couple awarded highest MS Australia accolade

Two fundraisers from Sydney’s Northern Beaches have been formally recognised for their years of service improving the lives of people affected by Multiple Sclerosis (MS).

Carol Langsford (OAM) and Roy Langsford (OAM), founders of the Trish MS Research Foundation have been awarded the John...

20 November 2013

Collaroy couple awarded highest MS Australia accolade

Two fundraisers from Sydney’s Northern Beaches have been formally recognised for their years of service improving the lives of people affected by Multiple Sclerosis (MS).

Carol Langsford (OAM) and Roy Langsford (OAM), founders of the Trish MS Research Foundation have been awarded the John...

27 August 2013

PBAC recommendations deliver promising news for people with MS

Multiple Sclerosis Australia (MSA) has welcomed the recent Pharmaceutical Benefits Advisory Committee (PBAC) recommendations of not one, but two oral multiple sclerosis (MS) medications.

Pages